- Home
- VERV vs VPG Comparison
VERV vs VPG Comparison
Compare VERV & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- VPG
- Stock Information
- Founded
- VERV 2018
- VPG 2009
- Country
- VERV United States
- VPG United States
- Employees
- VERV N/A
- VPG N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- VPG Electrical Products
- Sector
- VERV Health Care
- VPG Technology
- Exchange
- VERV Nasdaq
- VPG Nasdaq
- Market Cap
- VERV 384.2M
- VPG 363.1M
- IPO Year
- VERV 2021
- VPG N/A
- Fundamental
- Price
- VERV $11.06
- VPG $25.96
- Analyst Decision
- VERV Buy
- VPG Hold
- Analyst Count
- VERV 9
- VPG 1
- Target Price
- VERV $14.75
- VPG $31.00
- AVG Volume (30 Days)
- VERV 7.8M
- VPG 167.2K
- Earning Date
- VERV 08-07-2025
- VPG 08-05-2025
- Dividend Yield
- VERV N/A
- VPG N/A
- EPS Growth
- VERV N/A
- VPG N/A
- EPS
- VERV N/A
- VPG 0.23
- Revenue
- VERV $59,613,000.00
- VPG $297,480,000.00
- Revenue This Year
- VERV $27.75
- VPG N/A
- Revenue Next Year
- VERV N/A
- VPG $6.38
- P/E Ratio
- VERV N/A
- VPG $113.29
- Revenue Growth
- VERV 271.44
- VPG N/A
- 52 Week Low
- VERV $2.87
- VPG $18.57
- 52 Week High
- VERV $11.41
- VPG $35.11
- Technical
- Relative Strength Index (RSI)
- VERV 84.74
- VPG 51.80
- Support Level
- VERV $5.88
- VPG $25.51
- Resistance Level
- VERV $11.41
- VPG $26.76
- Average True Range (ATR)
- VERV 0.49
- VPG 1.19
- MACD
- VERV 0.64
- VPG -0.19
- Stochastic Oscillator
- VERV 95.00
- VPG 36.70
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.